Johnson & Johnson To Pay More Than $1.6 Billion To Resolve Healthcare Fraud Allegations

Monday, November 4, 2013

Tennessee will receive more than $12 million as part of a multistate and federal agreement resolving allegations pharmaceutical manufacturer Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., used deceptive marketing tactics. Specifically, the parties will pay $1.6 billion to resolve civil and criminal allegations of unlawful marketing practices to promote the sales of their atypical antipsychotic drugs, Risperdal and Invega. 

J&J and Janssen will pay in excess of $1.2 billion to the states and the federal government to resolve four qui tam, or whistleblower, lawsuits filed in the U.S. District Court for the Eastern District of Pennsylvania under the provisions of the federal False Claims Act and similar state False Claims statutes. In addition, Janssen Pharmaceuticals, Inc. will plead guilty in federal court to a criminal misdemeanor charge of misbranding Risperdal in violation of the Food, Drug, and Cosmetic Act.  As part of the criminal plea, Janssen has agreed to pay an additional $400 million in criminal fines and forfeitures.

“We applaud the cooperative work of the states and federal government to stop drug companies from illegally marketing potentially dangerous drugs to the public,” Tennessee Attorney General Bob Cooper said.  “The public needs to be able to trust those responsible for their health and well-being, and that includes drug manufacturers and those who prescribe medications.” 

J & J and Janssen allegedly promoted, marketed and introduced Risperdal and Invega into interstate commerce for uses not approved by the Food and Drug Administration and for uses that were not medically indicated.  Once the FDA approves a drug as safe and effective, a manufacturer cannot market or promote a drug for an “off-label” or other use not identified in the FDA-approved product label.  The states contend that during the period Jan. 1, 1999 through Dec. 31, 2005, the companies promoted Risperdal for off-label uses and made false and misleading statements about the safety and efficacy of Risperdal.

The states additionally allege J&J and Janssen paid illegal kickbacks to health care professionals and long-term care pharmacy providers to induce them to promote or prescribe Risperdal to children, adolescents and the elderly when there was no FDA approval for Risperdal use in these patient populations. The states further contend that from Jan. 1, 2007 through Dec. 31, 2009, the companies promoted Invega for off-label uses and made false and misleading statements about the safety and efficacy of Invega.  The manufacturers’ alleged unlawful conduct caused false and/or fraudulent claims to be submitted to or caused purchases by government funded health care programs, including the state Medicaid programs. 

As part of the global resolution, the companies will enter into a Corporate Integrity Agreement with the U.S. Department of Health and Human Services, Office of the Inspector General, which will monitor the company’s future marketing practices.

A team from the National Association of Medicaid Fraud Control Units worked with the federal government on the investigation and conducted the settlement negotiations with the pharmaceutical manufacturers on behalf of the states.  Team members included representatives from the Offices of the Attorneys General for the states of New York, Massachusetts, Ohio and California.

Diabetes Awareness Seminar Offered Nov. 5

There will be a Diabetes Awareness Seminar in the Ridgeside/Menlo Park Community in Brainerd on Saturday, Nov. 5, from 11 a.m.–1 p.m.  The seminar will be held at Greater Emmanuel Church, 400 Tunnel Blvd., and everyone is invited to attend this free event.   Registered nurses will provide:  updated diabetes awareness and maintenance information, blood pressure ... (click for more)

CADAS Recognized As One Of Tennessee’s Best By THDA

A sober-living facility being built by the Council for Alcohol and Drug Abuse Services was the focus of a Tennessee’s Best award Chattanooga-based nonprofit received last week during the 2016 Governor’s Housing Conference in Nashville. CADAS earned the Tennessee’s Best award from the Tennessee Housing Development Agency in the Housing Plus category. The Tennessee’s ... (click for more)

City Council Set To Act Tuesday Night On First Reading On Short Term Vacation Rentals

The City Council is set to take action on first reading on Tuesday night on a process to legalize short term vacation rentals in Chattanooga. The second and final reading is set for the following Tuesday. The final version comes after several public hearings and extensive discussion by the City Council and staff. Short term vacation rentals will be allowed in residences with ... (click for more)

16,858 Cast Ballots In First 3 Days Of Early Voting In Hamilton County

In the first three days of early voting in Hamilton County, 16,858 have already cast ballots. That includes 1,607 ballots received by mail. There were 5,157 who turned out at early voting sites on Wednesday and 5,083 on Thursday. The total on Friday was 5,011. Sites: Brainerd 1,084, 1080, 1,030 Election Office 1,848, 1,731, 1,698 Collegedale 956, 954, ... (click for more)

Please, No Short Term Vacation Rentals In My Neighborhood

Approval of the short term vacation rental item on the City Council agenda for Tuesday  will be the next step toward commercializing our residential properties and communities to benefit those more interested in making money than preserving an old, well-established, rich community of like-minded families.    Anything requiring a business license is ... (click for more)

Roy Exum: Kelly Could Win It

I am neither a sleuth nor an odds maker but I’d say there is about a one-in-three chance that Interim Hamilton County Department of Education Superintendent Kirk Kelly could become the permanent superintendent of our public schools next Thursday. I am assured something squirrelly is happening on our newly-seated school board. It has been seven months since the last superintendent ... (click for more)